In Group J, 375 DEGs were identified as targets of Keap1-Restored cells and were enriched with distinct functions in cardiovascular disease, signal transduction, cell motility, cancer, immune system process, biological adhesion, metabolic process, and cellular process (Figure S6A and Table S6). The gene discussed is KEAP1; the disease is cancer.